[go: up one dir, main page]

BR9904847A - Loção em emulsão de vitamina d3 ativa - Google Patents

Loção em emulsão de vitamina d3 ativa

Info

Publication number
BR9904847A
BR9904847A BR9904847-7A BR9904847A BR9904847A BR 9904847 A BR9904847 A BR 9904847A BR 9904847 A BR9904847 A BR 9904847A BR 9904847 A BR9904847 A BR 9904847A
Authority
BR
Brazil
Prior art keywords
active vitamin
active
vitamin
emulsion
lotion
Prior art date
Application number
BR9904847-7A
Other languages
English (en)
Other versions
BR9904847B1 (pt
Inventor
Seiji Mochinzuki
Wataru Akasofu
Katsumi Sakurai
Original Assignee
Teijin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teijin Ltd filed Critical Teijin Ltd
Publication of BR9904847A publication Critical patent/BR9904847A/pt
Publication of BR9904847B1 publication Critical patent/BR9904847B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

''LOçãO EM EMULSãO DE VITAMINA D~ 3~ ATIVA'' A presente invenção provê uma composição farmacêutica para administração local na forma de uma emulsão que contém vitamina D~ 3~ ativa e é apropriada para aplicação a áreas com cabelo, enquanto também tendo atividade farmacológica satisfatória, estabilidade de droga primária e estabilidade física. Esta loção contém (a) uma quantidade terapeuticamente efetiva de vitamina D~ 3~ ativa, (b) um componente de fase aquosa contendo um componente de óleo sólido compreendendo petrolato branco e um álcool superior, e um componente de óleo liquido compreendendo esqualano, (c) um componente de fase aquosa contendo polissacarídeo iónico, e (d) tensoativo não iónico, em que (1) o teor de referido polissacarídeo iónico é 0,3 a 1,0 partes em peso de preparação completa, (2) o teor de referido álcool superior é 0,2 a 1,0 partes em peso de preparação completa, e (3) o HLB de referido tensoativo não iónico é 10 ou mais.
BRPI9904847-7A 1998-03-04 1999-03-03 loção em emulsão de vitamina d3 ativa. BR9904847B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP5201998 1998-03-04
PCT/JP1999/001025 WO1999044617A1 (fr) 1998-03-04 1999-03-03 Lotions de vitamines d3 activees sous forme d'emulsion

Publications (2)

Publication Number Publication Date
BR9904847A true BR9904847A (pt) 2000-09-05
BR9904847B1 BR9904847B1 (pt) 2010-07-13

Family

ID=12903112

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI9904847-7A BR9904847B1 (pt) 1998-03-04 1999-03-03 loção em emulsão de vitamina d3 ativa.

Country Status (23)

Country Link
US (1) US6187763B1 (pt)
EP (1) EP0979654B1 (pt)
JP (1) JP4046363B2 (pt)
KR (1) KR100491202B1 (pt)
CN (1) CN1152689C (pt)
AT (1) ATE302608T1 (pt)
AU (1) AU744712B2 (pt)
BR (1) BR9904847B1 (pt)
CA (1) CA2288694C (pt)
CZ (1) CZ298971B6 (pt)
DE (1) DE69926843T2 (pt)
DK (1) DK0979654T3 (pt)
ES (1) ES2245511T3 (pt)
HU (1) HU226610B1 (pt)
IL (1) IL132750A (pt)
MY (1) MY122390A (pt)
NO (1) NO328086B1 (pt)
NZ (1) NZ500769A (pt)
PL (1) PL192825B1 (pt)
RU (1) RU2207843C2 (pt)
SK (1) SK285439B6 (pt)
TW (1) TWI240635B (pt)
WO (1) WO1999044617A1 (pt)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8263580B2 (en) 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
SI3146969T1 (en) * 1999-04-23 2018-08-31 Leo Pharma A/S Ointment for topical treatment of psoriasis
DE19955684A1 (de) * 1999-11-19 2001-05-23 Hilti Ag Ankerstange für Verankerungen mit organischen und/oder anorganischen Mörtelmassen
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
US6881427B2 (en) * 2002-01-31 2005-04-19 Alticor Inc. Topical anti-inflammatory composition containing linseed and licorice extracts
US20030185915A1 (en) * 2002-03-28 2003-10-02 Jaime Carlo Synergetic composition for the treatment of psoriasis and other skin disorders and method therefor
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US8119150B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
EP1556009B2 (en) 2002-10-25 2021-07-21 Foamix Pharmaceuticals Ltd. Cosmetic and pharmaceutical foam
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US20060018937A1 (en) * 2002-10-25 2006-01-26 Foamix Ltd. Steroid kit and foamable composition and uses thereof
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
JP2008540508A (ja) 2005-05-09 2008-11-20 フォーミックス エルティーディー． 起泡性ビヒクル及びその医薬組成物
PL2526930T3 (pl) 2005-06-01 2014-05-30 Glaxosmithkline Ip Dev Ltd Formulacja witaminowa
US8574568B2 (en) 2005-11-07 2013-11-05 Kaneka Corporation Reduced coenzyme Q10-containing composition comprising a surfactant which is stable against oxidation and method for stabilization by mixing with surfactant(s)
FR2893847B1 (fr) * 2005-11-30 2010-10-29 Galderma Sa Composition sous forme de spray comprenant un derive de vitamine d et une phase huileuse
WO2007086582A1 (ja) 2006-01-30 2007-08-02 Maruho Co., Ltd. ２２－オキサ－１α,２５－ジヒドロキシビタミンＤ3を含有する水中油型乳剤性ローション剤およびそれを用いた皮膚疾患の治療方法
DK2494959T3 (en) * 2006-07-05 2015-02-23 Foamix Pharmaceuticals Ltd Foam Bart dicarboxylsyrebærestof and pharmaceutical compositions thereof
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
WO2009069006A2 (en) 2007-11-30 2009-06-04 Foamix Ltd. Foam containing benzoyl peroxide
US8518376B2 (en) 2007-12-07 2013-08-27 Foamix Ltd. Oil-based foamable carriers and formulations
WO2009072007A2 (en) 2007-12-07 2009-06-11 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
EP2242476A2 (en) 2008-01-14 2010-10-27 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
WO2010125470A2 (en) 2009-04-28 2010-11-04 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013008A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
US8470304B2 (en) 2009-08-04 2013-06-25 Avidas Pharmaceuticals Llc Therapeutic vitamin D sun-protecting formulations and methods for their use
US8871184B2 (en) 2009-10-02 2014-10-28 Foamix Ltd. Topical tetracycline compositions
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
RU2602171C2 (ru) * 2011-03-24 2016-11-10 Лео Фарма А/С Композиция, содержащая липидные наночастицы и кортикостероид или производное витамина d
WO2013003803A1 (en) * 2011-06-29 2013-01-03 Avidas Pharmaceuticals Llc Topical formulations including lipid microcapsule delivery vehicles and their uses
NZ596015A (en) * 2011-10-26 2014-04-30 Anzamed Internat Ltd Method and composition for the treatment of pain and/or inflammation
US10398641B2 (en) 2016-09-08 2019-09-03 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne
CN114159567B (zh) * 2020-09-10 2023-03-31 南京海融医药科技股份有限公司 一种治疗皮肤病的混悬凝胶剂
JP7633712B2 (ja) * 2023-05-12 2025-02-20 アピ株式会社 外用組成物

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60174707A (ja) * 1984-02-21 1985-09-09 Kanebo Ltd 頭髪用化粧料
CA1272953A (en) * 1984-10-08 1990-08-21 Yuji Makino Pharmaceutical composition for external use containing active-type vitamin d.sub.3
JPS61212515A (ja) * 1985-03-16 1986-09-20 Taisho Pharmaceut Co Ltd 痔疾用軟膏
GB8904154D0 (en) * 1989-02-23 1989-04-05 Leo Pharm Prod Ltd Chemical compounds
JPH04230317A (ja) * 1990-12-27 1992-08-19 Lion Corp 乳液状組成物
RU2007179C1 (ru) * 1992-01-09 1994-02-15 Потапенко Александр Яковлевич Способ лечения псориаза и нейродермита
JP3480956B2 (ja) * 1992-10-16 2003-12-22 株式会社コーセー 皮膚外用剤
GB9226860D0 (en) * 1992-12-23 1993-02-17 Leo Pharm Prod Ltd Novel treatment
DE4328217C2 (de) * 1993-08-21 1996-01-11 Lohmann Therapie Syst Lts Therapeutisches System zur Behandlung der Psoriasis
CN1082818C (zh) 1993-09-01 2002-04-17 帝人株式会社 1α，24－(OH)2-V.D3乳膏组合物
JP3839502B2 (ja) 1994-03-03 2006-11-01 帝人株式会社 湿疹・皮膚炎群治療剤
JPH08295628A (ja) * 1995-04-27 1996-11-12 Teijin Ltd 脱毛症外用治療剤
JPH09249555A (ja) * 1996-03-12 1997-09-22 Kowa Co 乳剤性ローション

Also Published As

Publication number Publication date
CN1266370A (zh) 2000-09-13
KR20010012244A (ko) 2001-02-15
DK0979654T3 (da) 2006-01-02
ES2245511T3 (es) 2006-01-01
AU3274399A (en) 1999-09-20
AU744712B2 (en) 2002-02-28
HK1029933A1 (en) 2001-04-20
CA2288694C (en) 2009-11-17
HUP0002547A3 (en) 2001-03-28
HUP0002547A2 (hu) 2000-12-28
IL132750A0 (en) 2001-03-19
JP4046363B2 (ja) 2008-02-13
SK285439B6 (sk) 2007-01-04
TWI240635B (en) 2005-10-01
CZ390099A3 (cs) 2000-03-15
DE69926843T2 (de) 2006-06-22
CN1152689C (zh) 2004-06-09
NO995367D0 (no) 1999-11-03
HU226610B1 (en) 2009-04-28
NZ500769A (en) 2001-04-27
MY122390A (en) 2006-04-29
CA2288694A1 (en) 1999-09-10
EP0979654B1 (en) 2005-08-24
NO995367L (no) 1999-12-22
EP0979654A1 (en) 2000-02-16
WO1999044617A1 (fr) 1999-09-10
IL132750A (en) 2004-01-04
BR9904847B1 (pt) 2010-07-13
KR100491202B1 (ko) 2005-05-25
EP0979654A4 (en) 2002-05-08
CZ298971B6 (cs) 2008-03-26
PL192825B1 (pl) 2006-12-29
RU2207843C2 (ru) 2003-07-10
DE69926843D1 (de) 2005-09-29
NO328086B1 (no) 2009-11-30
PL336621A1 (en) 2000-07-03
ATE302608T1 (de) 2005-09-15
US6187763B1 (en) 2001-02-13
SK151499A3 (en) 2000-09-12

Similar Documents

Publication Publication Date Title
BR9904847A (pt) Loção em emulsão de vitamina d3 ativa
BR9915298A (pt) Composição lìquida, e, produto cosmético antiperspirante e/ou desodorante.
US4661524A (en) Topical treatment and composition
ATE211380T1 (de) Nanoemulsion aus fettsäureestern von oxyethyliertem oder nicht oxyethyliertem sorbitan und deren verwendungen in kosmetika, dermatologie und/oder ophthalmologie
BR0202483A (pt) Composição para reter ingredientes ativos, de cuidado pessoal dermicante não irritante resistente a água e processos para reter um ingrediente ativo em uma composição, e, para tratar a pele de mamìferos
HU218936B (hu) Stroncium (II) valamely szervetlen sóját tartalmazó bőriritáció elleni hatású topikális gyógyászati készítmények
BR9714334A (pt) Composição em gel transparente.
BR9911046A (pt) Uso de antidepressivos tricìclicos para analgesia local
BR9810729A (pt) Composição farmacêutica para compostos lipofìlicos ácidos disposta como uma formulação auto-emulsionante
BRPI0500402A (pt) microemulsão
CO4810297A1 (es) Cremas cosmeticas y farmaceuticas glicopilidinas
BR0317523A (pt) Processo para a preparação de formulações farmacêuticas de combinação utilizando fluidos supercrìticos
BR9811843A (pt) Sistema de agente de consevação para produtos de tratamento corporal
BRPI0410791A (pt) composição cremosa branca de alta viscosidade, e, creme branco livre de suspensão
DK0647129T3 (da) Præparat til topisk anvendelse
BR9813182A (pt) Composição água-em-óleo farmacêutica tópica sob a forma de um creme ou loção, e, processos para a preparação da mesma, e para o tratamento da dor
BR9714047A (pt) Derivados de ácido carboxìlico, uso dos mesmos, combinação destes com um ou mais compostos ativos, preparação de drogas para a administração oral e parenteral, e, antagonista de receptor de endotelina
KR950031084A (ko) 국소용 진양(鎭洋) 조성물
KR910021238A (ko) 켈로이드 치료제
Ricciatti-Sibbald et al. Dermatologic vehicles
JP2002020294A (ja) 皮膚外用剤
AR022069A1 (es) LOCIoN EN EMULSIoN DE VITAMINA D3 ACTIVA
BR9916524A (pt) Formulação farmacêutica tópica, uso de aciclovir, dimeticona e álcool poliìdrico miscìvel em água, e, processo para o tratamento de infecção viral
KR920021154A (ko) 만성 정맥혈울성 궤양의 치료와 상피재형성에 국부적으로 사용되는 제약학적 성분물
Coderch et al. Permeation Protection by Waterproofing Mucosal Membranes. Pharmaceutics 2023, 15, 2698

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DE INT.CL: A61K 31/59, A61K 31/593, A61K 9/07, A61K 47/10, A61K 47/36, A61K 47/36, A61K 47/44, A61K 8/06, A61K 8/67, A61K 8/73, A61P 17/00, A61P 17/06, A61P 17/02

Ipc: A61K 31/59 (2008.04), A61K 31/593 (2008.04), A61K

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 13/07/2010, OBSERVADAS AS CONDICOES LEGAIS.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 19A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)